| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | CN101478990A Combination preparations comprising bifeprunox and L-dopa |
| 07/08/2009 | CN101478989A Treatment agent for inflammatory bowel disease |
| 07/08/2009 | CN101474405A External-use preparation for treating onychomycosis |
| 07/08/2009 | CN101474404A Combined therapy using vascular endothelial growth factor receptor antagonist for inhibiting growth of tumor |
| 07/08/2009 | CN101474398A Use of inhibitors for the treatment of disorders related to RTK hyperfunction |
| 07/08/2009 | CN100510087C Modular transfection system |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509801C HIV inhibiting pyrimidines derivatives |
| 07/08/2009 | CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509058C Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508980C Compositions for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508961C Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy, and the pharmaceutical use thereof |
| 07/07/2009 | US7557195 granulocyte colony stimulating factor; provide a homogeneous product and a further purification process using the preparative column is not necessary; 1:1 molar ratio conjugates provide more improved stability and biological activity compared to G-CSF conjugates with several PEGs attached |
| 07/07/2009 | US7557194 Antibody materials for an IBD-associated polypeptide |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7557142 Administering otoprotective agent comprising methionine or derivative to patient undergoing chemotherapy; side effect reduction |
| 07/07/2009 | US7557139 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | US7556799 removing potassium from the gastrointestinal tract with a potassium-binding polymer; an alpha-fluoroacrylic acid polymer, or a difluoromaleic acid polymer crosslinked with vinylsulfonic acid, acrylic acid, vinyl phosphonate, vinyl-1,1-bisphosphonate, vinyl sulfonate, vinyl-1,2-disulfonate, itaconic aci |
| 07/07/2009 | US7556150 Dispenser for progestin used for acute and maintenance treatment of DUB |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2422711C Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 07/07/2009 | CA2344910C Method for treating renal disease, and pharmaceutical composition for treating renal disease |
| 07/07/2009 | CA2342628C The use of r-flurbiprofen for the treatment of inflammation |
| 07/07/2009 | CA2158479C Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
| 07/02/2009 | WO2009082698A1 Compositions for treatment of cognitive disorders |
| 07/02/2009 | WO2009082662A1 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia |
| 07/02/2009 | WO2009082038A2 Ampa receptor antagonists and zonisamide for epilepsy |
| 07/02/2009 | WO2009082014A1 Drug delivery system |
| 07/02/2009 | WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
| 07/02/2009 | WO2009081782A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/02/2009 | WO2009081117A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 07/02/2009 | WO2009080432A2 Composition for treatment of tuberculosis |
| 07/02/2009 | WO2009079877A1 The dermatological compound preparation for oxidative stress interference period |
| 07/02/2009 | WO2009079768A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | WO2009061445A3 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 07/02/2009 | WO2009050136A3 Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome |
| 07/02/2009 | WO2009027641A3 Materials and methods for exploiting synthetic lethality in mismatch repair-deficient cancers |
| 07/02/2009 | WO2009017838A3 Combinations of jak-2 inhibitors and other agents |
| 07/02/2009 | WO2008132719A3 Compositions and methods for cell killing |
| 07/02/2009 | WO2008074001A8 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 07/02/2009 | WO2008063943A4 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 07/02/2009 | WO2007127377A3 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170862 Use of c-kit inhibitors for the treatment of myeloma |
| 07/02/2009 | US20090170854 New Use |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170201 Compositions and methods of making embryonic stem cells |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169556 Vascular endothelial cell growth factor antagonists |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169527 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/02/2009 | US20090169521 Vascularized cardiac tissue and methods of producing and using same |
| 07/02/2009 | US20090169517 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules |
| 07/02/2009 | US20090169515 Canine probiotic bifidobacteria globosum |
| 07/02/2009 | US20090169513 Expression of virus entry inhibitors and recombinant AAV therefor |
| 07/02/2009 | US20090169506 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | CA2710490A1 Drug delivery system |
| 07/02/2009 | CA2708686A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | CA2707403A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/01/2009 | EP2075346A2 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/01/2009 | EP2075334A1 EG-VEGF nucleic acids and polypeptides and methods of use |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075031A1 Methods and systems for enhancing fluid flow trough an obstructed vascular site |
| 07/01/2009 | EP2075008A2 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 07/01/2009 | EP2074997A1 Use of Asimadoline for the treatment of digestive disorders |
| 07/01/2009 | EP2074996A1 Synergistic compositions with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074994A1 Enhanced ocular neuroprotection/neurostimulation |
| 07/01/2009 | EP2074990A1 Controlled release flurbiprofen and muscle relaxant combinations |
| 07/01/2009 | EP2073898A1 Complement inhibition for improved nerve regeneration |
| 07/01/2009 | EP2073859A1 Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
| 07/01/2009 | EP2073846A1 Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders |
| 07/01/2009 | EP2073827A2 Multiple sclerosis therapy |
| 07/01/2009 | EP2073813A2 Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent |
| 07/01/2009 | EP2073812A2 Histone acetyle transferase activators and histone deacetylase inhibitors in the treatment of alcoholism |
| 07/01/2009 | EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 07/01/2009 | EP1613296B1 Methods for treatment of parkinson's disease |
| 07/01/2009 | EP1529116B1 Method for predicting the responsiveness to treatment with rivastigmine based on the ApoE genotyp of dementia patients |
| 07/01/2009 | EP1511721B1 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1418864A4 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |